Organization · Incubator
RAD BioMed
RAD BioMed is an incubator based in Israel that focuses on early-stage ventures in the life sciences and Hi-Tech sectors. It aims to strengthen Israel's MedTech industry by leveraging the expertise of the RAD Bynet Group.
Overview
What RAD BioMed does
What RAD BioMed is
RAD BioMed is an incubator based in Israel that focuses on early-stage ventures in the life sciences and Hi-Tech sectors. It aims to strengthen Israel's MedTech industry by leveraging the expertise of the RAD Bynet Group.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Incubator
- Structured capabilities
- Funder · Program host
- Last reviewed
- March 5, 2026
What Incubator means
An incubator is a support environment for turning a nascent idea or early company into a startup that is more ready for customers, funding, or an accelerator.
Open the glossary entryOfficial channels
Find RAD BioMed elsewhere
Open the official website or a supported primary organization account.
Capability profile
RAD BioMed as a funder
Investment thesis
RAD BioMed invests in early-stage companies that provide disruptive solutions in the Health, Technology, and Energy sectors. The organization is dedicated to addressing real-world challenges and unmet needs through innovative ventures.
Focus narrative
RAD BioMed invests in early-stage companies across the Health, Technology, and Energy sectors. The organization seeks out companies that offer disruptive solutions to real-world challenges and unmet needs.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+
- Sectors
- HealthcareEnergy
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 10
- Recorded notable exits
- Vectorious, Belkin Vision, and Perflow
Portfolio context
Notable portfolio companies include: Vectorious: Developed therapies for structural heart disease; acquired by Edwards Lifesciences for $497 million. Belkin Vision: Provides a laser treatment for glaucoma; acquired by Alcon. REE Automotive: Focuses on e-mobility and innovative automotive systems; listed on NASDAQ through a merger. Perflow: Develops solutions for complex neurovascular treatments; acquired by a Chinese private equity firm. Moebius Medical: Engaged in drug development for osteoarthritis pain; signed a licensing deal with Sun Pharmaceutical Industries. CVaid Medical: Improves stroke triage. FEMSelect: Offers a mesh-free system for pelvic floor ligament fixation. Radiaction: Enhances safety and comfort for medical teams in interventional suites. Zsquare: Expands the reach of endoscopic assisted procedures. Synvaccine: Focuses on the rational design and construction of viral-based products.
Capability profile
RAD BioMed as a program host
Program thesis
RAD BioMed aims to strengthen Israel's MedTech sector by supporting early-stage companies that provide disruptive solutions to healthcare challenges.
Focus narrative
The program invests in early-stage companies across the Health, Technology, and Energy sectors. RAD BioMed is particularly interested in ventures that offer innovative and disruptive solutions to unmet medical needs, aiming to drive advancements in the MedTech landscape.
Value and support
Founders participating in RAD BioMed's program gain access to mentorship, industry expertise, and potential funding opportunities to accelerate their ventures. The incubator provides a supportive environment for startups to develop and refine their solutions.
Availability
- Application state
- Not published
Focus and fit
- Stages
- Pre-seed · Seed
- Sectors
- HealthcareEnergy
Alumni and track record
Alumni context
Notable alumni include Vectorious, acquired for $497 million by Edwards Lifesciences, and Belkin Vision, which provides laser treatment for glaucoma and was acquired by Alcon. Other successful alumni include REE Automotive, listed on NASDAQ, and Perflow, acquired by a Chinese private equity firm.
Common questions
What to know about RAD BioMed
Upseed classifies RAD BioMed under the Incubator organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.